Back to Market Feed

Product Information

XTAMPZA ER 13.5 MG CAPSULE is a brand product labeled by Collegium Pharmaceutical, Inc., priced at $8.9893 per EA under NDC 24510011510. Its NADAC has been published 381 times since Sep 20, 2017.

FDA first approved this application on Apr 26, 2016.

XTAMPZA ER 13.5 MG CAPSULE

OXYCODONE
$8.9893per EA
DEA Schedule CII

Strength

13.5 mg/1

NDC

24510011510

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

12/18/2024

Active Ingredients

OXYCODONE

Approval Type

New Drug (NDA)

FDA Application

NDA208090

FDA Approved

4/26/2016

On Market Since

5/10/2016

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for XTAMPZA ER 13.5 MG CAPSULE has been published 381 times since Sep 20, 2017, and over the history we have for it it has risen 71.7%. The table below summarizes its recorded NADAC range and movement.

Current price$8.9893 per EA
All-time high$9.0408 (May 15, 2024)
All-time low$5.2351 (Sep 20, 2017)
Median price$7.5851
Average price$7.4364
Largest weekly change+9.9% (Jan 1, 2020)
Weeks tracked381
Tracking sinceSep 20, 2017

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

+2.6%

5Y

+18.5%

All

+71.7%

Last surveyed Jan 1, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OXYCODONE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

HYCODAN 5 MG-1.5 MG/5 ML SOLN
Brand
64950034247•Genus Lifesciences Inc.
$0.0505
per ML
DILAUDID 5 MG/5 ML ORAL LIQUID
Brand
42858041616•Rhodes Pharmaceuticals L.P.
$0.8521
per ML
HYCODAN 5 MG-1.5 MG TABLET
Brand
64950020503•Genus Lifesciences Inc.
$1.0146
per EA
HYCODAN 5 MG-1.5 MG TABLET
Brand
64950020510•Genus Lifesciences Inc.
$1.0146
per EA
DILAUDID 4 MG TABLET
Brand
42858023401•Rhodes Pharmaceuticals L.P.
$3.9559
per EA
DILAUDID 4 MG TABLET
Brand
42858023450•Rhodes Pharmaceuticals L.P.
$3.9559
per EA
DEMEROL 50 MG/ML SYRINGE
Brand
00409117830•Hospira Inc.
$4.4738
per ML
MS CONTIN ER 15 MG TABLET
Brand
42858051501•Rhodes Pharmaceuticals L.P.
$4.6807
per EA
SUBOXONE 2 MG-0.5 MG SL FILM
Brand
12496120203•Indivior Inc.
$4.7854
per EA
ZUBSOLV 1.4-0.36 MG TABLET SL
Brand
54123091430•Orexo US, Inc.
$5.2632
per EA

Frequently asked questions

What is the NADAC price of XTAMPZA ER 13.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for XTAMPZA ER 13.5 MG CAPSULE, manufactured by Collegium Pharmaceutical, Inc., is $8.9893 per EA (NDC 24510011510), effective Jan 1, 2025.

How has the price of XTAMPZA ER 13.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for XTAMPZA ER 13.5 MG CAPSULE has risen 71.7%. It has been tracked across 381 weekly CMS publications since Sep 20, 2017.

What are the highest and lowest recorded NADAC prices for XTAMPZA ER 13.5 MG CAPSULE?

Since Sep 20, 2017, the NADAC for XTAMPZA ER 13.5 MG CAPSULE has ranged from a low of $5.2351 (Sep 20, 2017) to a high of $9.0408 (May 15, 2024), with a median of $7.5851 per EA.

Are there cheaper alternatives to XTAMPZA ER 13.5 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of XTAMPZA ER 13.5 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures XTAMPZA ER 13.5 MG CAPSULE?

XTAMPZA ER 13.5 MG CAPSULE (NDC 24510011510) is labeled by Collegium Pharmaceutical, Inc., and CMS classifies it as a brand product.